Eye Health Guide

Fluorescein Angiography

What fluorescein angiography is, why it’s performed, what to expect during the procedure, and how the results are used.

Fluorescein angiography is one of the classic tests in retinal medicine, and it is still extremely useful. A fluorescent dye injected into a vein reaches the eye within seconds, and a specialized camera captures its passage through the retinal circulation. That lets ophthalmologists see blood flow, leakage, blocked areas, and abnormal new vessels in a way ordinary examination cannot match. Newer imaging tests, especially OCT, have changed retinal practice dramatically, but fluorescein angiography still answers questions that structure alone cannot.

Fluorescein angiography at a glance

  • A fluorescent dye, sodium fluorescein, is injected into a vein and photographed as it travels through the retinal blood vessels
  • The test helps diagnose and monitor conditions including wet AMD, diabetic retinopathy, retinal vein occlusion, and uveitis
  • The procedure usually takes about 10 to 20 minutes in the clinic
  • The dye temporarily turns the skin and urine yellow-orange for up to 24 hours
  • Serious allergic reactions are rare but possible, which is why the test is performed in a medical setting
  • The dye is not the same as iodine contrast used in CT scans and does not carry the same kidney risk profile

Why fluorescein angiography is performed

Diagnosing retinal vascular disease

The main strength of fluorescein angiography is that it shows what retinal blood vessels are actually doing. Leaking vessels become brighter over time because dye escapes into surrounding tissue. Blocked vessels leave dark areas where perfusion is absent. Abnormal new vessels reveal themselves by their irregular shape and early, often dramatic leakage.

In diabetic retinopathy, angiography can show capillary dropout, leaking microaneurysms, and the extent of neovascularization. That can help guide laser planning and clarify how active the disease really is. Sometimes the retinal photograph looks bad but the leakage pattern matters more. Sometimes it is the other way around.

Evaluating age-related macular degeneration

In wet AMD, fluorescein angiography helps identify the location, size, and behavior of choroidal neovascularization beneath or within the retina. OCT has become the main monitoring tool for most patients during treatment, largely because it is quick and non-invasive, but angiography still has value when the presentation is complex, when lesion type matters, or when the clinician needs to know exactly where leakage is coming from.

Assessing retinal vein occlusion

After a retinal vein occlusion, angiography maps how much retina is no longer being perfused. That matters because ischemic retina is much more likely to drive new vessel growth. The test also shows how much macular leakage is contributing to visual loss, which can affect treatment planning and prognosis.

Investigating uveitis and other conditions

In uveitis and other inflammatory disease, fluorescein angiography can reveal vascular leakage, optic disc leakage, cystoid macular edema, and inflammatory patterns that may not be obvious on ordinary examination or color photographs. It is especially helpful when the retina looks only mildly abnormal but the patient is describing symptoms that suggest more is going on.

A 2x2 fluorescein angiography panel showing four retinal images: top left a normal retina with orderly vessel filling and no leakage, top right wet age-related macular degeneration with choroidal neovascular leakage near the macula, bottom left retinal vein occlusion with dilated tortuous veins and diffuse leakage, and bottom right diabetic macular edema with macular leakage and scattered microaneurysms.
Fluorescein angiography patterns: normal retina (top left), wet AMD with CNV (top right), retinal vein occlusion (bottom left), and diabetic macular edema (bottom right).

What to expect during the procedure

Preparation

No fasting is needed. The eyes are dilated about 20 to 30 minutes before the test, which means near vision will be blurred and light sensitivity will linger for a few hours afterward. Driving yourself home is usually a bad idea. Bring sunglasses and plan transport.

The team should know about prior reactions to fluorescein, significant allergies, asthma, pregnancy, or breastfeeding. Kidney disease is much less of a concern here than it is with CT contrast, but relevant medical history still matters because this is an injected dye study, not a casual photograph.

The injection and photography

The patient sits at a retinal camera. A small IV line or needle is placed in a vein, usually in the arm or hand. Baseline images are taken first. The dye is then injected, and photography begins immediately, capturing the arterial phase, capillary filling, venous filling, and then later recirculation. The first two to three minutes are often the most informative, but late images can matter just as much because persistent brightness may reveal leakage that was not obvious at the start.

A patient-friendly medical illustration of fluorescein angiography in an eye clinic, showing a person seated at a retinal imaging camera while an eye care professional operates the device, with a small IV line placed at the inner elbow to deliver the fluorescein dye.
Fluorescein angiography is performed with retinal imaging after dye is injected through a small IV line.

During the procedure

Patients are asked to keep their eyes open and look steadily at fixation targets during the photographs. Some people feel a brief warm flush, nausea, or lightheadedness just after the dye is injected. That usually fades quickly. Sneezing is also surprisingly common. It looks dramatic the first time, but it is a known reaction and usually not important.

Fluorescein angiography vs OCT: what each provides

OCT gives cross-sectional structural images of the retina with remarkable detail. It shows fluid, membranes, swelling, and layer disruption quickly and without any injection. That convenience is exactly why it has become the main follow-up tool for many retinal diseases.

But OCT and fluorescein angiography are not interchangeable. OCT shows structure. Fluorescein angiography shows blood flow behavior, vessel leakage, and perfusion. That distinction still matters a great deal. For many complex retinal problems, especially widespread ischemia or uncertain neovascular activity, angiography remains the more informative test.

After the procedure

The dye and its effects

Sodium fluorescein is cleared through the kidneys. For several hours after the test, the skin may look slightly yellow, especially in fair-skinned people, and the urine often becomes bright yellow-orange. That is expected. It is not blood, not liver failure, and not a sign anything went wrong. Drinking water helps clear the dye more quickly. If breastfeeding, many clinics advise discarding expressed milk for 24 hours afterward.

Interpreting the results

The angiogram is interpreted alongside the examination, the history, and other imaging such as OCT. The result is not just descriptive. It often changes management directly. Leakage patterns can influence laser planning, help explain unexplained visual loss, or clarify whether aggressive anti-VEGF treatment is needed now versus later.

Seek medical attention after fluorescein angiography if you notice

  • Hives, itching, or skin rash developing during or after the procedure
  • Difficulty breathing, throat tightening, or swelling of the face or lips
  • Feeling faint, dizzy, or severely nauseous after leaving the clinic
  • Redness, swelling, or pain at the injection site that worsens over the following 24 hours, possible dye extravasation

Mild nausea right after injection is common and usually brief. Serious allergic reactions are uncommon, but when they happen they can escalate quickly. If symptoms begin after you have left the clinic, seek urgent medical care.

Frequently asked questions

  • Is fluorescein angiography painful?

    Not exactly. The dilation drops can sting briefly, the IV or needle feels like any ordinary cannulation, and the camera flashes are bright and sometimes annoying. Most patients tolerate the test well, but very few would call it pleasant.

  • Is fluorescein the same as the contrast dye used in CT scans?

    No. Sodium fluorescein is a different substance from iodinated CT contrast and gadolinium used in MRI. It does not carry the same kidney injury concerns as iodinated contrast, though allergic-type reactions can still occur.

  • How long does the yellow skin discoloration last?

    Usually several hours. The yellow tint often fades within 6 to 12 hours, while the urine may stay bright for up to 24 hours. It looks strange, but it is expected.

  • Can I have fluorescein angiography if I am allergic to other things?

    It depends on what those allergies are and how severe they have been. A general allergy history does slightly raise the chance of a reaction, but many allergic patients undergo fluorescein angiography without trouble. The most important thing is to tell the team clearly about prior reactions to fluorescein, anaphylaxis, or active asthma.

  • Will I need repeat fluorescein angiography?

    Sometimes, but not always. OCT has replaced repeated angiography for routine follow-up in many diseases, so fluorescein angiography is now used more selectively when blood flow or leakage patterns need to be reassessed, or when the story has become more complicated.

  • Can I wear my contact lenses to the appointment?

    No, not ideally. Contact lenses should be removed before dilation, and soft lenses should not be reinserted for at least 24 hours because fluorescein can stain them. Bring glasses.

For further reading: Age-related macular degeneration, National Eye Institute and Age-related macular degeneration, American Academy of Ophthalmology.